Parkinson disease-related deaths among adults aged 65 years and older are down in 2024 compared with prior years.

Teens in the US report using fewer anabolic steroids compared to 2 decades ago, but there is a sharp increase in creatine use.

Metastatic progression reduction is associated with GLP-1 RA initiation after cancer diagnosis across multiple solid tumors.

Most children who progress to clinical type 1 diabetes can be identified with population-based screening for early-stage type 1 diabetes.

A new tool may help support optometrist and ophthalmologist decisions as they develop care plans for adolescents with amblyopia.

Cardiovascular disease risk factor associations with social determinants of health vary significantly by nativity among Black US adults.

The FDA has approved the oral antiviral Xocova (ensitrelvir) for postexposure prophylaxis of COVID-19 in adults and adolescents.

Veterans with narcolepsy type 1 or other narcolepsy face elevated risk for all-cause mortality compared with a general sleep clinic cohort.

Among children with enuresis, problematic media use is associated with sleep disturbances and poor sleep hygiene.

A stroke metabolite score comprising 4 validated metabolites improves ischemic stroke risk prediction beyond traditional risk factors in women.

Patients with Gaucher disease type 1 face high age-specific prevalence of Parkinson disease and possible parkinsonian syndrome by age 80 years.

The FDA has extended the PDUFA date for Beren Therapeutics’ adrabetadex New Drug Application to November 17, 2026, to allow for the review of additional data updates for infantile-onset Niemann-Pick ...